Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Gritstone Bio Inc
(NQ:
GRTS
)
0.9627
+0.0927 (+10.66%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Gritstone Bio Inc
Gritstone bio Announces Positive Preliminary Progression-free Survival and Long-term Circulating Tumor DNA (ctDNA) Data from Phase 2 Portion of Ongoing Phase 2/3 Study of its Personalized Cancer Vaccine, GRANITE, in Front-line Metastatic Microsatellite
April 01, 2024
From
Gritstone bio
Via
GlobeNewswire
Gritstone bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Updates
March 05, 2024
From
Gritstone bio
Via
GlobeNewswire
Gritstone bio Reports Third Quarter 2023 Financial Results and Provides Corporate Updates
November 08, 2023
From
Gritstone bio
Via
GlobeNewswire
Genevant Sciences LNP Technology Used in samRNA Covid-19 Vaccine Candidate Behind Gritstone bio’s BARDA Award
October 12, 2023
From
Genevant Sciences
Via
GlobeNewswire
Presentations at IDWeek 2023 Highlight Potentially Differentiated Immunogenicity of Gritstone bio’s Next Generation COVID-19 Vaccine
October 11, 2023
From
Gritstone bio
Via
GlobeNewswire
Gritstone bio Awarded BARDA Contract to Conduct Comparative Phase 2b Study Evaluating Next-Generation Vaccine Candidate for COVID-19 Valued at up to $433 Million
September 27, 2023
From
Gritstone bio
Via
GlobeNewswire
Gritstone bio Reports Second Quarter 2023 Financial Results and Provides Corporate Updates
August 09, 2023
From
Gritstone bio
Via
GlobeNewswire
Gritstone bio Reports First Quarter 2023 Financial Results and Provides Corporate Updates
May 11, 2023
From
Gritstone bio
Via
GlobeNewswire
Gritstone bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Updates
March 09, 2023
From
Gritstone bio
Via
GlobeNewswire
InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Announces New Board Member
December 05, 2022
Via
Investor Brand Network
Topics
Artificial Intelligence
Intellectual Property
Exposures
Artificial Intelligence
Intellectual Property
Product Safety
Predictive Oncology Appoints Leading Biopharma Executive Matthew J. Hawryluk Ph.D. to the Board of Directors
December 05, 2022
From
Predictive Oncology Inc.
Via
GlobeNewswire
Gritstone Reports Third Quarter 2022 Financial Results and Provides Business Update
November 03, 2022
From
Gritstone bio
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.